HER2 dimerization inhibitor pertuzumab - Mode of action and clinical data in breast cancer

Nadia Harbeck*, Matthias W. Beckmann, Achim Rody, Andreas Schneeweiss, Volkmar Müller, Tanja Fehm, Norbert Marschner, Oleg Gluz, Iris Schrader, Georg Heinrich, Michael Untch, Christian Jackisch

*Corresponding author for this work
    37 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'HER2 dimerization inhibitor pertuzumab - Mode of action and clinical data in breast cancer'. Together they form a unique fingerprint.

    Medicine & Life Sciences